6
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1373 |
Ac2-26
|
||
Ac2-26 TFA is an active n-terminal peptide in annexin A1 (AnxA1), which can alleviate acute lung injury caused by ischemia-reperfusion. | |||
T83727 |
Tat-NTS Peptide TFA
Tat-Nuclear Translocation Signal Peptide |
||
Tat-NTS肽是一种能穿透细胞的肽,由HIV-1 Tat蛋白的转导域与对应于脂联素A1重复III域残基228-237的10个氨基酸肽链接而成,扮演核转运信号(NTS)的角色。它通过阻断脂联素A1与进口素β之间的蛋白质-蛋白质相互作用,阻止脂联素A1在初级鼠海马神经元中的核内转运。Tat-NTS抑制初级鼠海马神经元在葡萄糖-氧剥夺及再灌注诱导的细胞凋亡。在体内,Tat-NTS(10 mg/kg)有效减少了由中脑动脉闭塞(MCAO)引起的缺血-再灌注损伤模型小鼠的梗塞体积和神经元凋亡,并缩短了在Morris水迷宫测试中达到平台的时间。 | |||
T83667 |
A11 TFA
CPP-EYVQTVKSSKG |
||
A11是一种细胞穿透肽,由HIV-1 Tat蛋白质转导域与对应于脂联素A1 N末端第20至30残基的11氨基酸肽连接而成。它减少脂联素A1与Eph受体酪氨酸激酶A2(EphA2)的结合,并在HK1鼻咽癌(NPC)细胞中增加EphA2的泛素化。A11(10 µM)抑制HK1和5-8F NPC细胞的增殖、迁移和侵袭。在体内,A11减少5-8F和HK1 NPC小鼠异种移植模型中的肿瘤体积。 | |||
TP1321 |
Ac2-26 TFA (151988-33-9 free base)
Ac2-26 TFA |
||
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue. | |||
T75800 |
Ac2-26 TFA
|
||
Ac2-26 TFA,是膜联蛋白 A1 (AnxA1) 的活性 N-末端肽,可减轻缺血再灌注诱导的急性肺损伤。Ac2-26 还降低 AnxA1 蛋白表达,抑制受损肺组织中NF-κB 和 MAPK 通路活化。 | |||
TP1373L |
Ac2-26 acetate
|
NF-κB | NF-κB |
Ac2-26 acetate 是一种膜联蛋白 A1(AnxA1) 的活性 N 末端肽。 Ac2-26 acetate 降低 AnxA1 蛋白表达并抑制受损肺组织中 NF-κB 和 MAPK 通路的激活。 Ac2-26 acetate 可减轻缺血再灌注诱导的急性肺损伤。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-00799 |
ANXA1 Protein, Mouse, Recombinant (His)
Calpactin-2,LPC1,Annexin-1,Annexin I,ANX |
Mouse | E. coli |
Atherosclerosis, characterized by the formation of fat-laden plaques, is a chronic inflammatory disease. ABCA1 promotes cholesterol efflux, reduces cellular cholesterol accumulation, and regulates anti-inflammatory activities in an apoA-I- or ANXA1-dependent manner. The latter activity occurs by mediating the efflux of ANXA1, which plays a critical role in anti-inflammatory effects, cholesterol transport, exosome and microparticle secretion, and apoptotic cell clearance. ANXA1 Protein, Mouse, Re... | |||
TMPJ-00766 |
ANXA1 Protein, Human, Recombinant
Chromobindin-9,Phospholipase A2 Inhibitory Protein,Annex... |
Human | E. coli |
Annexin A1 is the first characterized member of the annexin family of proteins and is able to bind to cellular membranes in a calcium-dependent manner, promoting membrane fusion and endocytosis. Annexin A1 has anti-inflammatory properties and inhibits phospholipase A2 activity. Annexin A1 also has roles in many diverse cellular functions, such as membrane aggregation, inflammation, phagocytosis, proliferation, apoptosis, and tumorigenesis and cancer development. ANXA1 is strongly expressed on th... | |||
TMPK-00768 |
ANXA1 Protein, Human, Recombinant (His)
Annexin A1,Calpactin II,ANX1,p35,Lipocorti... |
Human | E. coli |
Atherosclerosis, characterized by the formation of fat-laden plaques, is a chronic inflammatory disease. ABCA1 promotes cholesterol efflux, reduces cellular cholesterol accumulation, and regulates anti-inflammatory activities in an apoA-I- or ANXA1-dependent manner. The latter activity occurs by mediating the efflux of ANXA1, which plays a critical role in anti-inflammatory effects, cholesterol transport, exosome and microparticle secretion, and apoptotic cell clearance. ANXA1 Protein, Human, Re... | |||
TMPK-01291 |
ANXA1 Protein, Cynomolgus, Recombinant (His)
Lipocortin I,Calpactin-2,ANX1,ANXA1,Annexin |
Cynomolgus | E. coli |
Atherosclerosis, characterized by the formation of fat-laden plaques, is a chronic inflammatory disease. ABCA1 promotes cholesterol efflux, reduces cellular cholesterol accumulation, and regulates anti-inflammatory activities in an apoA-I- or ANXA1-dependent manner. The latter activity occurs by mediating the efflux of ANXA1, which plays a critical role in anti-inflammatory effects, cholesterol transport, exosome and microparticle secretion, and apoptotic cell clearance. ANXA1 Protein, Cynomolgu... |